We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-14.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.1B
AUM Growth
-$2.86B
Cap. Flow
-$262M
Cap. Flow %
-2%
Top 10 Hldgs %
37.9%
Holding
1,479
New
56
Increased
646
Reduced
399
Closed
58

Top Buys

Rank Stock Value
1
MAA icon
Mid-America Apartment Communities
MAA
+$174M
2
EQIX icon
Equinix
EQIX
+$83.3M
3
DLR icon
Digital Realty Trust
DLR
+$82.9M
4
PLD icon
Prologis
PLD
+$52.3M
5
INVH icon
Invitation Homes
INVH
+$39.6M

Top Sells

Rank Stock Value
1
AMT icon
American Tower
AMT
+$263M
2
VICI icon
VICI Properties
VICI
+$230M
3
ESS icon
Essex Property Trust
ESS
+$96.1M
4
VTR icon
Ventas
VTR
+$61.2M
5
EBIZ icon
Global X E-commerce ETF
EBIZ
+$39.2M

Sector Composition

Rank Sector Weight
1 Real Estate 60.75%
2 Technology 8.8%
3 Healthcare 4.18%
4 Consumer Discretionary 3.61%
5 Financials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRMY icon
1101
Harmony Biosciences
HRMY
$2.07B
$11K ﹤0.01%
220
+49
+29% +$2.21K
LEGN icon
1102
Legend Biotech
LEGN
$3.68B
$11K ﹤0.01%
199
-4,517
-96% -$191K
PTCT icon
1103
PTC Therapeutics
PTCT
$6.06B
$11K ﹤0.01%
266
+60
+29% +$2.1K
BEAM icon
1104
Beam Therapeutics
BEAM
$2.62B
$10K ﹤0.01%
262
+63
+32% +$2.5K
OUT icon
1105
Outfront Media
OUT
$5.66B
$10K ﹤0.01%
598
-130
-18% -$2.83K
PCRX icon
1106
Pacira BioSciences
PCRX
$1.05B
$10K ﹤0.01%
169
+39
+30% +$2.56K
FATE icon
1107
Fate Therapeutics
FATE
$270M
$9K ﹤0.01%
360
+81
+29% +$2.23K
INSM icon
1108
Insmed
INSM
$22.8B
$9K ﹤0.01%
445
+100
+29% +$2.1K
ZLAB icon
1109
Zai Lab
ZLAB
$2.11B
$9K ﹤0.01%
255
+50
+24% +$1.76K
ARVN icon
1110
Arvinas
ARVN
$526M
$8K ﹤0.01%
198
+44
+29% +$2.21K
ACAD icon
1111
Acadia Pharmaceuticals
ACAD
$4.44B
$7K ﹤0.01%
469
– –
BCRX icon
1112
BioCryst Pharmaceuticals
BCRX
$2.45B
$7K ﹤0.01%
692
+167
+32% +$1.72K
IRWD icon
1113
Ironwood Pharmaceuticals
IRWD
$630M
$7K ﹤0.01%
573
+95
+20% +$1.12K
RLAY icon
1114
Relay Therapeutics
RLAY
$3.94B
$7K ﹤0.01%
405
+88
+28% +$1.89K
SAGE
1115
DELISTED
Sage Therapeutics
SAGE
$7K ﹤0.01%
220
+48
+28% +$1.61K
TWST icon
1116
Twist Bioscience
TWST
$5.38B
$7K ﹤0.01%
210
+42
+25% +$1.49K
CCXI
1117
DELISTED
ChemoCentryx, Inc.
CCXI
$7K ﹤0.01%
265
+61
+30% +$1.34K
GBT
1118
DELISTED
Global Blood Therapeutics, Inc.
GBT
$7K ﹤0.01%
214
– –
ALLO icon
1119
Allogene Therapeutics
ALLO
$563M
$6K ﹤0.01%
535
+119
+29% +$1.06K
AMPH icon
1120
Amphastar Pharmaceuticals
AMPH
$881M
$6K ﹤0.01%
165
– –
IOVA icon
1121
Iovance Biotherapeutics
IOVA
$2.1B
$6K ﹤0.01%
586
+128
+28% +$1.68K
KRYS icon
1122
Krystal Biotech
KRYS
$10.5B
$6K ﹤0.01%
96
+20
+26% +$1.24K
LGND icon
1123
Ligand Pharmaceuticals
LGND
$5.93B
$6K ﹤0.01%
101
+22
+28% +$1.25K
LYEL icon
1124
Lyell Immunopharma
LYEL
$318M
$6K ﹤0.01%
46
+11
+31% +$1.12K
XENE icon
1125
Xenon Pharmaceuticals
XENE
$6.29B
$6K ﹤0.01%
198
+57
+40% +$1.72K
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2022 Portfolio in Review

As of Q2 2022, Daiwa Securities Group held 1,479 positions worth $13.1B, down 18% from $16B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q2 2022 filing shows 56 new, 646 increased, 399 reduced and 58 closed positions. Its largest new stake was HDFC Bank: 143,030 shares worth $3.93M. The largest sale was American Tower, an estimated $263M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 60% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q2 2022 buy was HDFC Bank: 143,030 shares worth $3.93M.
  • Daiwa Securities Group added most to Mid-America Apartment Communities in Q2 2022, an estimated $174M increase.
  • Daiwa Securities Group's biggest Q2 2022 reduction was American Tower, cutting an estimated $263M.
  • Daiwa Securities Group fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $7.68M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13.1B portfolio in Q2 2022.
  • Daiwa Securities Group opened 56 new positions and closed 58 in Q2 2022.
  • Daiwa Securities Group's portfolio value fell 18% quarter-over-quarter to $13.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2022, filed 9 Aug 2022.